Phase III Trial of Single-Agent Pemetrexed (Alimta) Versus the Combination of Carboplatin and Pemetrexed in Patients With Advanced Non-small-cell Lung Cancer and Performance Status of 2
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Pemetrexed (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 17 Jun 2013 Results published in the Journal of Clinical Oncology.
- 01 May 2013 New trial record